Clinical trial
TM30339: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Repeated Subcutaneous Dose-range Study Designed to Determine the Weight Loss in Obese Subjects.
NCT00746824 is registered in ClinicalTrials.gov with 7TM Pharma A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TM30339: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Repeated Subcutaneous Dose-range Study Designed to Determine the Weight Loss in Obese Subjects.
- Lead sponsor
- 7TM Pharma A/S
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2008
- Completion date
- March 31, 2009
- Enrollment
- 192 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.